| 17699867 |
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor
Guo, T,
Agaram, NP,
Wong, GC,
Hom, G,
D'Adamo, D,
Maki, RG,
Schwartz, GK,
Veach, D,
Clarkson, BD,
Singer, S,
DeMatteo, RP,
Besmer, P,
Antonescu, CR
|
Clin. Cancer Res. |
2007 |
| 17363509 |
Resistance to c-KIT kinase inhibitors conferred by V654A mutation
Roberts, KG,
Odell, AF,
Byrnes, EM,
Baleato, RM,
Griffith, R,
Lyons, AB,
Ashman, LK
|
Mol. Cancer Ther. |
2007 |
| 30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Serrano, C,
Mariño-Enríquez, A,
Tao, DL,
Ketzer, J,
Eilers, G,
Zhu, M,
Yu, C,
Mannan, AM,
Rubin, BP,
Demetri, GD,
Raut, CP,
Presnell, A,
McKinley, A,
Heinrich, MC,
Czaplinski, JT,
Sicinska, E,
Bauer, S,
George, S,
Fletcher, JA
|
Br. J. Cancer |
2019 |
